Wuxi JV is about building in China's late-stage sector says PRA
PRA wants to build its late-phase offering in China and has committed to provide staff and knowhow to Wuxi Pharmatech joint venture.
Archives for January 15, 2013
New Guideline Lays Out Minimum Content of a Clinical Trial Protocol
Experts have created a new minimum content guideline addressing quality gaps seen in many trial protocols.
FDA Shifts Focus to Abuse-Deterrent Generic Opioid Development
The US Food and Drug Administration (FDA) can require opioid generics to have abuse-deterrent properties if the same requirements are applicable to their brand name counterparts, FDA Commissioner Margaret Hamburg said in a letter to Rep. Fred Upton...
Bioavailability to drive drug delivery deals in 2013 says analyst
Demand for improved bioavailability solutions will drive drug delivery dealmaking in 2013 according to a pharmaceutical industry expert.
American Capital to expand Cambridge Major Labs' API biz
Cambridge Major Labs’ (CML) new private-equity investor plans to expand the CMO’s chemistry and API business and assess cross selling synergies with other firms in its portfolio.
update
Greece is the word: BASF tells Pronova shareholders revised bid is fair value
BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs.
BASF ups offer for omega-3 API maker Pronova
BASF has increased its cash offer for omega-3 API maker Pronova Biopharma to €684m.
Aptuit’s global connection whizz API to market
Aptuit says that collaboration amongst its global facilities was a key factor in bringing Lomitapide to market.